Microbiome Influence on Endocrine Function: A Novel Approach to Type 2 Diabetes Treatment

Main Article Content

Monalisa Khuntia, Prof. Susant Mishra, Dr. Rajesh Kumar Padhi, Ramaballav Mahapatra, Arundhati Guru, Sanjay Chand, Dr. Soumya Sucharita, Prof. Abhaya Kumar Sahoo, Dr. Hariballav Mahapatra

Keywords

Microbiome, Endocrine function, Type 2 Diabetes, Insulin sensitivity, GLP-1, Adiponectin, Prebiotics, Probiotics, Glycemic control, Metabolic dysregulation

Abstract

Increasing incidence of T2D has led to the focus of the scientific community for developing alternative therapeutic approaches to meet challenges of present-day drug therapies. This paper aims at exploring the effect of the microbiome on endocrine activity primarily considering the effect of the composition of gut microbiota to glucose and insulin. In reviewing the current literature, we identify ways though which the microbiome influences hormones including insulin, GLP-1, as well as adiponectin. Further, we briefly discuss promising pharmacologic strategies for modulating the gut microbiota of T2D patients including prebiotics, probiotics, and dietary interventions for glycaemic regulation.

Abstract 73 | PDF Downloads 47

References

Adeshirlarijaney, A., & Gewirtz, A. T. (2020). Considering gut microbiota in treatment of type 2 diabetes mellitus. Gut Microbes, 11(3), 253–264.
Aydin, Ö., Nieuwdorp, M., & Gerdes, V. (2018). The gut microbiome as a target for the treatment of type 2 diabetes. Current Diabetes Reports, 18, 1–11.
Bui, T. P. N., & de Vos, W. M. (2021). Next-generation therapeutic bacteria for treatment of obesity, diabetes, and other endocrine diseases. Best Practice & Research Clinical Endocrinology & Metabolism, 35(3), 101504